P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and...

9

Transcript of P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and...

Page 1: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 2: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 3: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 4: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 5: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 6: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 7: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 8: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the
Page 9: P8113-20171114075819 - novartis.dk Mel… · Novartis may disclose publicly the financial and non-financial support provided to Grant Recipient, including, without limitation, the

Alex P. Lange The author has no financial interest to disclose.

Alex P. Lange The author has no financial interest to disclose.

Financial Instruments: Disclosures · Significance of financial instruments for financial position and performance 7 An entity shall disclose information that enables users of its

Financial Instruments: Disclosures · Significance of financial instruments for financial position and performance 7 An entity shall disclose information that enables users of its

Vademecum Novartis

Vademecum Novartis

Alfred J. Cossari, MD Port Jefferson, NY. Financial Disclosure I have no financial interests or relationships to disclose.

Alfred J. Cossari, MD Port Jefferson, NY. Financial Disclosure I have no financial interests or relationships to disclose.

Disclose Disclose Disclose

Disclose Disclose Disclose

B2 novartis

B2 novartis

I have no financial relationships to disclose. I will not discuss off-label and/or

I have no financial relationships to disclose. I will not discuss off-label and/or

Table of Contents - NASPGHAN...of an educational activity are required to disclose relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure

Table of Contents - NASPGHAN...of an educational activity are required to disclose relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure

Novartis india

Novartis india

Low-Fat Dietary Pattern and Survival after Breast Cancer ... · Prentice RL, PhD . I have the following financial relationships to disclose: Consultant for: Novartis, Genentech, Amgen,

Low-Fat Dietary Pattern and Survival after Breast Cancer ... · Prentice RL, PhD . I have the following financial relationships to disclose: Consultant for: Novartis, Genentech, Amgen,

Dr. Woolsey’s Disclosure I have no industry or other financial relationships to disclose.

Dr. Woolsey’s Disclosure I have no industry or other financial relationships to disclose.

I have the following financial interests or relationships to disclose: I have the following financial interests or relationships to disclose: –OMIC-Ophthalmic.

I have the following financial interests or relationships to disclose: I have the following financial interests or relationships to disclose: –OMIC-Ophthalmic.

Financial/Commercial Relationships Disclosures - … · Financial/Commercial Relationships DISCLOSURES ... Genentech/Roche, Lilly, AstraZeneca, BMS, Merck, Ventana, Novartis, HTG

Financial/Commercial Relationships Disclosures - … · Financial/Commercial Relationships DISCLOSURES ... Genentech/Roche, Lilly, AstraZeneca, BMS, Merck, Ventana, Novartis, HTG

I have no financial relationship(s) to disclose relevant to my presentation.

I have no financial relationship(s) to disclose relevant to my presentation.

Presentation - Novartis

Presentation - Novartis

I have financial relationships to disclose Consultant for: st Jude

I have financial relationships to disclose Consultant for: st Jude

financial analysis of novartis

financial analysis of novartis

The authors have no financial interest to disclose Topical IL-1ra provided by TheraKine , Inc.

The authors have no financial interest to disclose Topical IL-1ra provided by TheraKine , Inc.

Corporate governance - Novartis

Corporate governance - Novartis

Patti Parsons has no relevant financial and/or non-financial relationships to disclose.

Patti Parsons has no relevant financial and/or non-financial relationships to disclose.